References
<A NAME="RS03803ST-1">1</A>
Nestler JE.
Jakubowicz DJ.
Reamer P.
Jun RD.
Allan GJ.
New
Engl. J. Med.
1999,
340:
1314
<A NAME="RS03803ST-2">2</A>
Larner J.
Int.
J. Exp. Diabetes Res.
2002,
3:
47
<A NAME="RS03803ST-3">3</A>
Liu C.
Nahorski SR.
Potter BVL.
Carbohydr.
Res.
1992,
234:
107
<A NAME="RS03803ST-4">4</A>
Liu C.
Stefan R.
Nahorski SR.
Potter BVL.
Biorg. Biomed. Chem.
1994,
2:
253
<A NAME="RS03803ST-5">5</A>
Mato JM.
Kelly KL.
Abler A.
Jarret L.
Corkey BE.
Cashell JA.
Zopf Z.
Biochem.
Biophys. Res. Commun.
1987,
146:
746
<A NAME="RS03803ST-6">6</A>
Larner J.
Huang LC.
Schwartz CFW.
Oswald AS.
Shen TY.
Kinter M.
Tang G.
Zeller K.
Biochem. Biophys.
Res. Commun.
1988,
151:
1416
<A NAME="RS03803ST-7">7</A> Review:
Khiar N.
Martín-Lomas M. In Carbohydrate Mimics. Concepts and Methods
Chapleur Y.
Wiley VCH;
Weinheim:
1998.
p.433-462; and references therein
<A NAME="RS03803ST-8">8</A>
Dietrich H.
Espinosa JF.
Chiara JL.
Jiménez-Barbero J.
León Y.
Varela Nieto I.
Mato JM.
Cano FH.
Foces-Foces C.
Martín-Lomas M.
Chem.-Eur. J.
1999,
5:
320
<A NAME="RS03803ST-9">9</A>
Martín-Lomas M.
Khiar N.
García S.
Koessler JL.
Nieto PM.
Rademacher TW.
Chem.-Eur.
J.
2000,
6:
3608
<A NAME="RS03803ST-10">10</A>
Jaramillo C.
Chiara JL.
Martín-Lomas M.
J. Org. Chem.
1994,
59:
3135
<A NAME="RS03803ST-11">11</A>
Martín-Lomas M.
Flores-Mosquera Khiar N.
Eur. J. Org. Chem.
2000,
1539
<A NAME="RS03803ST-12A">12a</A>
Cid MB.
Bonilla JB.
Dumarcay S.
Alfonso F.
Martín-Lomas M.
Eur. J. Org.
Chem.
2002,
881
<A NAME="RS03803ST-12B">12b</A>
Bonilla J.
Bmuñoz-Ponce JL.
Nieto PM.
Cid MB.
Khiar N.
Martín-Lomas M.
Eur.
J. Org. Chem.
2002,
889
<A NAME="RS03803ST-13">13</A> Review:
Jones DP.
Varela-Nieto I.
Mol. Med.
1999,
5:
505
<A NAME="RS03803ST-14A">14a</A>
Chiara JL.
Valle N.
Tetrahedron:
Asymmetry
1995,
6:
1895
<A NAME="RS03803ST-14B">14b</A>
Kornienko A.
d’Alarcao M.
Tetrahedron Lett.
1997,
53:
6497
<A NAME="RS03803ST-14C">14c</A>
Kwon Y.-U.
Lee C.
Chung S.-K.
J. Org.
Chem.
2002,
67:
3327
<A NAME="RS03803ST-15">15</A>
Brammer LE.
Hudliky T.
Tetrahedron:
Asymmetry
1998,
9:
2011
<A NAME="RS03803ST-16">16</A>
Sung-Kee Chung S.-K.
Yu SH.
Biorg. Biomed. Chem. Lett.
1996,
6:
1461
<A NAME="RS03803ST-17">17</A>
Takahashi H.
Kittaka H.
Ikegani S.
J.
Org. Chem.
2001,
66:
2705
<A NAME="RS03803ST-18">18</A>
Pietrusiewicz KM.
Salamonczyk GM.
Bruzik KS.
Tetrahedron
1992,
48:
5523
<A NAME="RS03803ST-19">19</A>
Takahashi Y.
Nakayama H.
Katagiri K.
Ichikawa K.
Ito N.
Takita T.
Takeuchi T.
Miyatake T.
Tetrahedron Lett.
2001,
42:
1053
<A NAME="RS03803ST-20A">20a</A>
Yu J.
Spencer JB.
J.
Org. Chem.
1996,
61:
3234
<A NAME="RS03803ST-20B">20b</A>
Yu J.
Spencer JB.
Tetrahedron Lett.
2001,
42:
1053
<A NAME="RS03803ST-21">21</A>
(-)2-Deoxy-scyllo-inosose
(5). To a solution of 3,4,5,6-tetra-O-benzyl-1-O-trifluoromethanesulfonyl-l-myo-inositol
(4, 105 mg, 0.156 mmol), in a mixture of
dry toluene and DMF (1/1, 5 mL), cesium trifluoracetate
(192 mg, 0.781 mmol) and a catalytic amount of DMAP, were added.
After 48 h at room temperature, the resulting slurry was diluted with
EtOAc, washed with water, brine, dried over Na2SO4 and
concentrated. The solvent was evaporated and the residue purified
by flash chromatography (hexane/EtOAc, 4:1), to give 81
mg (0.155 mmol, 100%). [α]D -22.0° (c= 0.5, CHCl3).
Anal. Calcd. for C34H34O5: C, 78.13%;
H, 6.55%; found : C, 77.70%; H, 6.66%.
<A NAME="RS03803ST-22">22</A>
Zinder BB.
Hawryluk NA.
Org. Lett.
2000,
2:
635
<A NAME="RS03803ST-23">23</A>
Das SK.
Mallet J.-M.
Sinaӱ P.
Angew.
Chem. Int. Ed. Engl.
1997,
36:
493
<A NAME="RS03803ST-24">24</A>
Rudolf MT.
Li W.-H.
Wolfson N.
Traynor-Kaplan AE.
Schultz C.
J. Med. Chem.
1998,
41:
3635
<A NAME="RS03803ST-25">25</A>
Berlin WK.
Zhang W.-S.
Shen TY.
Tetrahedron
1991,
47:
1
<A NAME="RS03803ST-26">26</A>
Masamune S.
Choy W.
Petersen JS.
Sita LR.
Angew. Chem., Int. Ed.
Engl.
1985,
23:
1
<A NAME="RS03803ST-27">27</A>
Spijker NM.
van Boeckel CAA.
Angew.
Chem., Int. Ed. Engl.
1991,
30:
180
<A NAME="RS03803ST-28">28</A>
Kinzi W.
Schmidt RR.
Liebigs Ann Chem.
1985,
1537
<A NAME="RS03803ST-29">29</A>
2-Amino-2-deoxy-
d
-glucopyranosyl-α(1→1)-
l
-
chiro
-inositol
(IIa): 1H NMR (500 MHz, D2O): δ = 5.08
(d, 1 H,
J = 3.65
Hz, H1
′); 4.13 (t, 1 H, J = 3.81 Hz, H1);
4.0 (t, 1 H, J = 3.51 Hz, H6);
3.88-3.85 (m, 2 H, H6
′a and
H5); 3.79-3.71 (m, 3 H, H6
′b,
H4 and H2); 3.65 (m, 1 H, H5
′);
3.58 (t, 1 H,
J = 9.61
Hz, H3); 3.53 (t, 1 H, J = 9.61
Hz, H3
′); 3.38 (t, 1 H, J = 9.31 Hz, H4
′)
and 2.73 (dd, 1 H, J = 10.4
Hz, 3.51 Hz, H2
′). FAB HRMS calcd
for C12H23NO10 + Na+:
364.1219, found 364.1209. 2-Amino-2-deoxy-
d
-glucopyranosyl-β(1→1)-l-
chiro
-inositol (IIb): 1H
NMR (500 MHz, D2O):
δ = 4.43
(d, 1 H, J = 8.24 Hz, H1
′);
4.17 (t, 1 H, J = 3.66 Hz, H1);
4.14 (t, 1 H, J = 3.60 Hz, H6);
3.88-3.68 (m, 6 H, 2H6
′, H2,
H5, H3 and H4); 3.46 (m, 1 H, H5
′);
3.40 (t, 1 H, J = 8.85 Hz, H4
′);
3.36 (t, 1 H, J = 9.31 Hz, H3
′)
and 2.69 (dd, 1 H,
J = 9.30
Hz, 8.24 Hz, H2
′). FAB HRMS calcd
for C12H23NO10 + Na+:
364.1219, found 364.1223.